Top compounds associated with response to DEFB107A


Feature Type Standardized
Nominal ANOVA
mRNA cediranib CTRPv2 pan-cancer AAC -0.054 0.3
mRNA alisertib CTRPv2 pan-cancer AAC -0.031 0.3
mRNA prima-1 CTRPv2 pan-cancer AAC -0.031 0.3
mRNA betulinic acid CTRPv2 pan-cancer AAC -0.038 0.3
mRNA simvastatin CTRPv2 pan-cancer AAC -0.039 0.3
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.036 0.3
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC -0.052 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA ZSTK474 CTRPv2 pan-cancer AAC -0.037 0.3
Download CSV